The combination of high clinical quality, high support, and solid trust metrics makes this one of the most well-rounded programs in our directory
Doogue MP, Begg EJ, Moore PM, Lunt H, Pemberton CJ, Zhang M
All trials adopted an open-label design, except for the study of Aroda et al., which was a double-blind trial
Eric Perakslis Hear directly from our Chief Science Officer about how Shotsy is built on a foundation of science, safety, and data privacy
*The Food and Drug Administration has not evaluated these statements
Master Reference Table: All 24 Peptides at a Glance *Scroll right on mobile to see all columns